Echocardiographic comparison of left ventricular structure and function in hypertensive patients with primary

Ronen Goldkorn1, Alexei Yurenev, Jon Blumenfeld

  • 1Division of Cardiology, New York Presbyterian Hospital-Weill Cornell Medical Center, New York 10021, USA.

Insights

Excess aldosterone in primary aldosteronism does not significantly alter left ventricular (LV) structure or systolic function in hypertensive patients compared to essential hypertension. This suggests aldosterone may not independently impact LV remodeling in human hypertension.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Endocrinology

Background:

  • Aldosterone's role in myocardial remodeling and fibrosis is known in experimental renovascular hypertension.
  • Its specific effects on left ventricular (LV) structure and function in hypertensive patients remain unclear.

Purpose of the Study:

  • To investigate whether excess aldosterone in primary aldosteronism affects LV geometry and systolic function in hypertensive patients.
  • To compare LV structure and function between patients with primary aldosteronism and essential hypertension matched for key clinical parameters.

Main Methods:

  • A comparative study of 35 patients with primary aldosteronism and 35 controls with essential hypertension.
  • Assessment of LV mass, endocardial and midwall fractional shortening, and afterload-corrected midwall shortening (observed/predicted midwall shortening ratio).
  • Statistical analysis included logistic regression adjusting for covariates like blood pressure, BMI, and gender.

Main Results:

  • Patients with primary aldosteronism and essential hypertension exhibited similar LV dimensions, wall thickness, and mass.
  • No significant differences were found in endocardial or midwall fractional shortening, or afterload-corrected midwall shortening between the groups.
  • Logistic regression analysis did not reveal statistical differences in LV geometry or systolic function based on aldosterone status.

Conclusions:

  • Patients with primary aldosteronism show comparable LV geometry and systolic function to essential hypertension patients when matched for age, gender, and blood pressure.
  • These findings challenge the notion of a significant independent association between aldosterone and LV remodeling or function in human hypertension.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...